Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Baxter files European marketing application for HemAssist

May 8, 1997

CSID enzyme replacement therapy submitted for approval

May 8, 1997

FDA decision on generic Premarin

May 8, 1997

Kissei licenses antidiabetic agent to Purdue

May 8, 1997

Genentech enters into agreement for embryonic stem cell renewal factor

May 8, 1997

Senetek seeks European approval of erectile dysfunction therapy

May 8, 1997

DEA recommends descheduling of Redux

May 7, 1997

Fosamax cleared as preventive medication in osteoporosis

May 7, 1997

Gene Logic and Johns Hopkins University enter into research collaboration

May 7, 1997

SmithKline Beecham's Androderm now available as a single patch system

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...